Article ISI SCOPUS
FRONTIERS IN IMMUNOLOGY  (2016)

Treatment with Dexamethasone and Monophosphoryl lipid a removes Disease-associated Transcriptional signatures in Monocyte-Derived Dendritic cells from rheumatoid arthritis Patients and confers Tolerogenic Features

Garcia-Gonzalez, PA; Sepulveda-Gutierrez, A; Mehdi, AM; Nel, HJ; Larrondo, ML; Hilkens, CM

Keywords: tolerance, dendritic cells, rheumatoid arthritis, transcriptome, cell-based therapy

Más información

Título según WOS: Treatment with Dexamethasone and Monophosphoryl lipid a removes Disease-associated Transcriptional signatures in Monocyte-Derived Dendritic cells from rheumatoid arthritis Patients and confers Tolerogenic Features
Título según SCOPUS: Treatment with dexamethasone and monophosphoryl lipid a removes disease-associated transcriptional signatures in monocyte-derived dendritic cells from rheumatoid arthritis patients and confers tolerogenic features
Título de la Revista: FRONTIERS IN IMMUNOLOGY
Volumen: 7
Número: OCT
Editorial: FRONTIERS MEDIA SA
Fecha de publicación: 2016
Idioma: English
DOI:

10.3389/fimmu.2016.00458
Notas: ISI, SCOPUS